Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02400658 · ClinicalTrials.gov registry record · NA

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

A NA study of Breast Cancer, sponsored by Shayna Showalter, MD.

Active
Registry status
NA
Development phase
358
Enrollment target
3
Study locations

NCT02400658: Active NA study of Breast Cancer, sponsored by Shayna Showalter, MD.

NCT02400658 is a NA study of Breast Cancer that is active but no longer recruiting, run by Shayna Showalter, MD. The registered enrollment target is 358 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02400658, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Shayna Showalter, MD.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
358 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate an investigational way to provide radiation therapy to treat early-stage breast cancer at the time of surgery.

Conditions Studied

Interventions

  • DEVICE IORT with CT-Guided HDR Brachytherapy

Study Locations (3)

New Jersey

  • Hackensack Meridian Health - John Theurer Cancer Center - Hackensack

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 358 participants
Start Date 2015-03
Est. Completion 2027-09
Phase NA
Shayna Showalter, MD

3 total trials

What the registry record for NCT02400658 still lists

NCT02400658 is an interventional study that assigns participants to a tested intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT with CT-Guided HDR Brachytherapy is the first listed.

NCT02400658 reports a single indexed study location in New Jersey, Pennsylvania, Virginia.

Frequently Asked Questions

What is clinical trial NCT02400658 about?

NCT02400658 is a clinical study titled "Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer". The purpose of this study is to evaluate an investigational way to provide radiation therapy to treat early-stage breast cancer at the time of surgery.

What is the current status of trial NCT02400658?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 358 participants. The study started on 2015-03. Estimated completion is 2027-09.

What conditions does trial NCT02400658 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02400658?

The interventions under investigation include: IORT with CT-Guided HDR Brachytherapy (DEVICE).

Who is sponsoring clinical trial NCT02400658?

This trial is sponsored by Shayna Showalter, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02400658 being conducted?

This trial has 3 study locations across New Jersey, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02400658's enrollment target sits among peer trials

358 253rd of 1224 higher than 972 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04373317 · 358 participants · Phase 4

    Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

  • NCT05684965 · 358 participants · Phase 1

    XTX301 in Patients With Advanced Solid Tumors

  • NCT05824975 · 358 participants · Phase 1

    A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

  • NCT06480227 · 358 participants · NA

    Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02400658, the US trial registry maintained by the National Library of Medicine. NCT02400658 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.